NCT00924729

Study of Ocular Penetration of Topically Administered Fluoroquinolones

Parallel-group Study of Ocular Penetration of Peri-operative Topically Administered Fluoroquinolones With Cataract Surgery

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Johns Hopkins University · Academic / Other
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

This study is being conducted to evaluate the intraocular penetration of Moxifloxacin 0.5% ophthalmic solution (Vigamox) and Besifloxacin 0.6% ophthalmic suspension (Besivance) after pre-operative topical administration in subjects undergoing cataract surgery.

Conditions

• Cataract Extraction

Interventions

Type	Name	Description
DRUG	Moxifloxacin 0.5% ophthalmic solution	Administer moxifloxacin study drug prior to cataract surgery.
DRUG	Besifloxacin 0.6% ophthalmic suspension	Administer besifloxacin study drug prior to cataract surgery.

Timeline

• Start date: 2009-09-01
• Primary completion: 2009-10-01
• Completion: 2009-11-01
• First posted: 2009-06-19
• Last updated: 2017-10-24
• Results posted: 2010-03-11

Locations

1 site across 1 country: United States